| Financial Year |
March 31 2023 |
| Monetary Funds |
47,343,347.90 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
19,842,942.48 |
| Accounts Receivable |
56,943,808.41 |
| Advances to Suppliers |
4,072,611.26 |
| Other Receivables |
20,835,336.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
76,472,097.24 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,400,490.61 |
| Total Current Assets |
236,594,634.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
17,359,460.05 |
| Fixed Assetes |
383,550,028.48 |
| Under-construction Projects |
4,286,122.48 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
66,779,337.57 |
| R&D expenses |
37,065,651.29 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
13,488,276.16 |
| Other Non-Current Assets |
3,510,792.46 |
| Sub-Total of Non-Current Assets |
590,664,821.52 |
| Total Assets |
827,259,456.27 |
| Short-Term Loans |
80,069,568.04 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,604,726.80 |
| Accounts Payable |
93,854,856.51 |
| Accounts Received In Advance |
11,346.74 |
| Employee Compensation Payable |
6,400,986.80 |
| Taxes Payable |
5,321,849.09 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
10,116,183.30 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,885,272.76 |
| Other Current Liabilities |
16,565,956.01 |
| Sub-Total of Current Liabilities |
242,231,470.19 |
| Long-term Loans |
13,320,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
30,151,666.67 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
8,903,768.82 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
55,481,919.39 |
| Total Liabilities |
297,713,389.58 |
| Paid-In Capital(Or Share Stock) |
176,000,000.00 |
| Capital Surplus |
288,469,403.58 |
| Surplus Reserve |
17,076,787.10 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
47,999,876.01 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
529,546,066.69 |
| Owner's Equity（Stockholder's Equity） |
529,546,066.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
827,259,456.27 |
